Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 11:54 AM ET

Pharmaceuticals

Company Overview of Mankind Pharma Limited

Company Overview

Mankind Pharma Limited manufactures pharmaceutical products. It offers products in the areas of antibiotics, antifungals, gastrointestinals, anthelmintics, cardiovascular, dermal, ophthalmic, antibacterial, acute and chronic disease, antipsychotic, veterinary, antidiabetic, hypothyroidism, cough prepration, antimalarial, antimigraine, anti-viral, steriods, opthalmic, gynaecological, and anti-asthmatics. The company also provides consumer products, such as emergency contraceptives, pregnancy detection cards, antacids, condoms, sanitary napkins, body sprays, pregnancy test kits, toothbrushes, and sweeteners. It sells its products through a network of stockists and C&F agents. Mankind Pharma Li...

236, Okhla

Phase-III

New Delhi,  110 020

India

Founded in 1991

Phone:

91 11 4654 1400

Fax:

91 11 4654 1382

Key Executives for Mankind Pharma Limited

Chairman, Chief Executive Officer and Managing Director
Age: 59
Whole Time Director
Age: 67
Whole Time Director
Age: 23
Director of Marketing and Director
Director of Marketing and Director
Compensation as of Fiscal Year 2014.

Mankind Pharma Limited Key Developments

Mankind Pharma Keen to Spend INR 5 Billion for Expansion in Local Market

Mankind Pharmaceuticals is ready to invest around INT 5 billion to acquire local pharma companies in order to strengthen its presence in the domestic market. The pharma company is not the sole candidate in this race as almost all the leading Indian pharma majors are adopting the same measure for their expansion.

Mankind Pharma Seeks Acquisitions

Mankind Pharma Limited is ready to invest around INR 5 billion to buy local rivals and is keen on licensing deals with foreign firms, a top official at the firm said. The company is also exploring buying established brands to expand its domestic footprint, Managing Director Sheetal Arora told Reuters in a phone interview. In scouting for local companies with niche capabilities, New Delhi-based Mankind would be competing with nearly all the top Indian pharma players, who are keen to expand domestically.

Mankind Pharma to Establish New Facility in Indian State of Rajasthan

Mankind Pharma announced that the company is constructing a manufacturing facility in Rajasthan, India. The facility will reportedly be used to manufacture active pharmaceutical ingredients (APIs) and is likely to become operational by the end of 2015. The facility is the result of a reported INR 1 billion investment. Further details of the facility have not been announced.

Similar Private Companies By Industry

Company Name Region
SBS Biotech Limited Asia
Covalent Laboratories Private Limited Asia
Troikaa Pharmaceuticals Ltd. Asia
Bharat Medical Corp. Asia
JB Pharma SEZ Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mankind Pharma Limited, please visit www.mankindpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.